U.S. Tech Hardware Stock News

Structure Therapeutics Inc. recently reported a second-quarter net loss of US$61.66 million, widening from US$26.03 million a year ago, and for the six-month period, the net loss also increased to US$108.49 million from US$52.07 million in the previous year. Following these results, the company filed for a US$250 million follow-on equity offering and a shelf registration allowing future issuance of various securities including American Depositary Shares, preferred shares, debt securities,...

Earlier this month, Quanta Services completed a US$1.5 billion multi-tranche senior notes offering with maturities spanning 2028, 2031, and 2035, intending to use the proceeds to repay existing borrowings under its commercial paper program and senior credit facility. By extending its debt maturity profile and locking in fixed interest rates, Quanta Services could see changes in its financial flexibility and interest expenses, influencing its future capital allocation decisions. We'll explore...

GRAIL, Inc. reported second quarter and six-month results for the period ended June 30, 2025, showing sales of US$34.38 million and US$63.51 million respectively, with net losses narrowing substantially from the prior year and impairment charges decreasing to US$28 million from a very large US$1.42 billion a year earlier. This sharp reduction in both net loss and impairment charges points to improved operational discipline and financial stability at the company. We'll explore how GRAIL's...

Earlier this past week, Kymera Therapeutics announced positive results from its first KT-621 clinical trial, which delivered strong efficacy and a placebo-like safety profile, alongside new collaborations with Gilead and Sanofi and disclosure of a cash reserve near US$1 billion by July's end. An important takeaway is that Kymera's strengthened pipeline through high-profile partnerships and a substantial cash runway may provide meaningful support for future research and development...

Viridian Therapeutics recently reported its second quarter and six-month earnings for 2025, revealing a wider net loss of US$100.74 million and US$187.65 million respectively, both larger than the losses reported a year earlier. Alongside these results, the company filed a new shelf registration to potentially offer 11,228,650 shares, which may reflect ongoing capital needs and could influence future dilution concerns. We'll examine how the combination of larger losses and the shelf...

Formula One Group reported its second quarter 2025 earnings on August 7, showing sales of US$1.20 billion and net income of US$382 million, both up sharply from a year earlier. This marks a very large year-over-year increase in net income, highlighting the impact of strong commercial partnerships and expanding media revenues. We'll explore how this significant boost in quarterly profits could influence analyst expectations about Formula One Group's earnings trajectory and risk profile. These...

Abbott Laboratories recently reported strong financial results, achieving 18% annual earnings per share growth over the past three years and a 5.9% rise in revenue, while insider ownership was valued at US$1.1 billion. This combination of robust performance and significant insider confidence underlines stability in the company's leadership and alignment with shareholder interests. We'll explore how Abbott's large insider ownership and earnings momentum may shape its investment narrative...

BlackLine recently announced leadership changes, with founder Therese Tucker transitioning from Co-CEO to Founder and Owen Ryan assuming the CEO role, alongside board updates and the appointment of a new Lead Independent Director following the release of its second quarter earnings results. An important insight is that these developments occurred just as BlackLine reported higher year-over-year revenue but saw a pronounced decline in net income and earnings per share, reflecting operational...

PENN Entertainment recently completed a repurchase of 6,920,104 shares for US$115.6 million, reported improved second-quarter financial results, issued new revenue guidance, launched the FanCenter feature on ESPN BET, and made changes to its Compliance Committee. An important insight is PENN's investments in digital product development and compliance, alongside capital returns, highlight a multifaceted approach to shareholder value and operational growth. We'll explore how PENN's new...

In recent days, Solaris Energy Infrastructure was highlighted in a widely read industry outlook alongside peers, drawing increased attention from investors following sector commentary focused on oil stockpiles and shifting capital spending priorities. The company’s inclusion as a promising trade idea has sparked renewed interest in its position within the energy sector, especially amid analyst debates on capital discipline and the demand outlook for energy infrastructure. We’ll explore how...

Earlier this month, LGI Homes withdrew its full year 2025 guidance citing market uncertainties and reported a year-over-year decline in second quarter net income to US$31.53 million from US$58.57 million. The company simultaneously launched new communities and expanded its product offerings, including 17 new floor plans in Minneapolis and the opening of Brayden Preserve near Raleigh-Durham, reflecting ongoing efforts to attract homebuyers despite current industry headwinds. We'll explore how...

Earlier this month, Universal Technical Institute reported higher third-quarter and year-to-date earnings, updated its fiscal 2025 guidance upward, and announced leadership changes at its San Antonio campus to support its skilled trades expansion. The addition of advanced EV diagnostic tools at multiple campuses and recent insider share purchases reflect broad-based efforts to address evolving industry needs and suggest growing internal confidence in UTI’s direction. We'll now explore how...

Earlier this month, ACADIA Pharmaceuticals reported second quarter 2025 earnings, highlighting revenue growth to US$264.57 million and adjusted its full-year guidance, raising the lower end for both total U.S. revenues and NUPLAZID net product sales expectations. While revenue increased from the prior year, net income and earnings per share declined slightly, suggesting that expectations for improved future performance drove market attention to the updated guidance. We’ll examine how the...

NCR Atleos Corporation recently reported higher net income and earnings per share for the second quarter of 2025, announced a new US$200 million share repurchase program, reaffirmed its 2025 guidance, and revealed expanded ATM partnerships with FCTI Inc. and Casey's. The FCTI collaboration points to one of the largest single service endpoint ATM deployments in the U.S. market, underscoring NCR Atleos' expanding reach in self-service financial solutions. We'll explore how the substantial...

10x Genomics, Inc. reported second quarter 2025 earnings earlier this month, posting revenue of US$172.91 million and a return to net profitability compared with a net loss in the same period last year. The company noted that its revenue guidance for the upcoming quarter reflects accelerated purchases from customers in China anticipating possible tariff changes, highlighting how regulatory factors can shift demand and impact reported results. We'll explore how 10x Genomics's return to...

APi Group recently reported strong results, highlighted by robust organic revenue and adjusted EBITDA growth in its core Safety Services segment, alongside upward full-year earnings estimate revisions and increased institutional interest. This momentum underscores the impact of heightened safety regulations and expanding recurring revenue on the company's market enthusiasm and operational performance. Next, we’ll examine how the positive shift in earnings outlook may influence APi Group’s...

Earlier this month, CoStar Group extended its legal battle by filing a copyright infringement lawsuit against Zillow, alleging unauthorized use and distribution of over 46,000 copyrighted images and seeking damages potentially exceeding US$1 billion. This development highlights ongoing competitive and legal tensions within the digital real estate marketplace, raising complex questions about intellectual property protection and industry relationships. We'll explore how investor concerns...

Warby Parker recently announced second-quarter 2025 earnings, reporting US$214.48 million in sales and a significant reduction in net loss compared to the previous year, alongside an increase in full-year revenue guidance and plans for 45 new store openings, including Target shop-in-shops. In addition to financial gains and positive outlook, the company is experiencing an executive transition, with Co-Founder and Co-CEO Dave Gilboa stepping in as interim principal financial officer following...

Root, Inc. recently reported second quarter 2025 results, announcing a net income of US$20.9 million, a turnaround from a net loss of US$7.8 million in the prior year, and improved earnings per share from both basic and diluted continuing operations. This marks the company's first return to profitability for both the quarter and year-to-date periods, reflecting a substantial shift in operating performance. We will examine how Root's return to profitability could influence its ongoing...

Sensient Technologies recently participated in Baird's Investor Day in St. Louis and held a special company call, both events taking place earlier this week. These activities have raised expectations among investors for potential new disclosures or updates that could signal meaningful shifts in the company's direction. We'll explore how Sensient's investor conference participation and special call may influence its outlook for natural colors and clean-label growth. We've found 19 US stocks...

Gibraltar Industries recently announced its second-quarter 2025 results, reporting increased sales of US$309.52 million but a decrease in net income to US$26 million compared to the previous year, along with updated full-year guidance projecting lower earnings per share for 2025. While sales growth continued, the company's forecast for reduced annual earnings per share compared to 2024 signals shifting profitability dynamics that may influence expectations for the rest of the year. We'll now...

Arrowhead Pharmaceuticals announced its third quarter and nine-month results for the period ended June 30, 2025, reporting US$27.77 million in quarterly sales and a net loss of US$175.24 million for the quarter, but a shift to net income of US$22.12 million for the nine months, compared to a loss of US$428.96 million a year earlier. This turnaround was driven by a very large year-on-year increase in year-to-date sales, resulting in the company returning to profitability over the nine-month...

In recent weeks, Vertex Pharmaceuticals reported strong second-quarter financial results with US$2.96 billion in revenue and announced its investigational pain therapy VX-993 did not meet the primary endpoint in a Phase 2 trial, resulting in the decision not to pursue it further as a monotherapy for acute pain. This combination of a pipeline setback and robust financial performance, alongside continued share repurchases and confirmation of annual revenue guidance, reflects both the strengths...

Earlier this month, Surgery Partners reported second-quarter 2025 results with sales rising to US$826.2 million and a significantly lower net loss compared to the previous year, while reaffirming its full-year revenue guidance of US$3.3 billion to US$3.45 billion; the company also announced Wayne S. DeVeydt’s immediate resignation as Executive Chairman and director, appointing Blair E. Hendrix as the new Board Chairman and reducing the Board size to 10 directors. Despite the leadership...